Additionally, YAP and TAZ do not equally contribute to e.g., breast cancer and liver fibrosis in nonalcoholic steatohepatitis [4, 30], further substantiating the idea that both factors must be comparatively investigated under distinct disease conditions. The gene discussed is WWTR1; the disease is metabolic dysfunction-associated steatohepatitis.